Henry Schein Company Profile (NASDAQ:HSIC)

About Henry Schein

Henry Schein logoHenry Schein, Inc. is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company's segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments. This segment distributes consumable products, equipment, pharmaceuticals, infection-control products and vitamins. Its global dental group serves office-based dental practitioners, schools and other institutions. The technology and value-added services segment group provides software, technology and other value-added services to health care practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis, e-services, as well as education services for practitioners.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment Wholesale
  • Sub-Industry: Health Care Distributors
  • Exchange: NASDAQ
  • Symbol: HSIC
  • CUSIP: 80640710
Key Metrics:
  • Previous Close: $172.64
  • 50 Day Moving Average: $160.83
  • 200 Day Moving Average: $158.29
  • 52-Week Range: $146.23 - $183.00
  • Trailing P/E Ratio: 28.67
  • Foreward P/E Ratio: 21.55
  • P/E Growth: 2.15
  • Market Cap: $13.90B
  • Outstanding Shares: 80,490,000
  • Beta: 1.02
  • Net Margins: 4.40%
  • Return on Equity: 18.15%
  • Return on Assets: 8.03%
  • Debt-to-Equity Ratio: 0.25%
  • Current Ratio: 1.61%
  • Quick Ratio: 0.89%
Additional Links:
Companies Related to Henry Schein:

Analyst Ratings

Consensus Ratings for Henry Schein (NASDAQ:HSIC) (?)
Ratings Breakdown: 5 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $181.88 (5.35% upside)

Analysts' Ratings History for Henry Schein (NASDAQ:HSIC)
DateFirmActionRatingPrice TargetDetails
2/22/2017Barrington ResearchReiterated RatingOutperform -> Outperform$185.00 -> $196.00View Rating Details
2/21/2017Evercore ISIBoost Price TargetHold$160.00 -> $178.00View Rating Details
1/10/2017GabelliUpgradeHold -> Buy$208.00View Rating Details
1/3/2017Robert W. BairdUpgradeNeutral -> Outperform$164.00 -> $170.00View Rating Details
12/6/2016Northcoast ResearchDowngradeBuy -> NeutralView Rating Details
11/3/2016J P Morgan Chase & CoReiterated RatingHold$163.00View Rating Details
11/3/2016Leerink SwannReiterated RatingHoldView Rating Details
10/11/2016Goldman Sachs Group, Inc. (The)UpgradeNeutral -> Buy$185.00View Rating Details
9/12/2016Bank of America CorpInitiated CoverageBuy$185.00View Rating Details
6/4/2016Credit Suisse GroupReiterated RatingHoldView Rating Details
2/11/2016Piper Jaffray CompaniesReiterated RatingNeutral$158.00 -> $159.00View Rating Details
11/5/2015Royal Bank Of CanadaBoost Price TargetOutperform$165.00 -> $170.00View Rating Details
7/30/2015Evercore Partners Inc.Reiterated RatingBuy -> HoldView Rating Details
(Data available from 2/22/2015 forward)


Earnings History for Henry Schein (NASDAQ:HSIC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/21/2017Q416$1.85$1.88$3.08 billion$3.12 billionViewN/AView Earnings Details
11/2/2016Q316$1.65$1.68$2.88 billion$2.87 billionViewN/AView Earnings Details
8/4/2016Q216$1.63$1.64$2.85 billion$2.87 billionViewN/AView Earnings Details
5/3/2016Q116$1.39$1.41$2.66 billion$2.70 billionViewListenView Earnings Details
2/10/2016Q415$1.65$1.67$2.82 billion$2.90 billionViewListenView Earnings Details
11/4/2015Q315$1.47$1.55$2.70 billion$2.70 billionViewListenView Earnings Details
7/29/2015Q215$1.46$1.46$2.68 billion$2.60 billionViewListenView Earnings Details
5/4/2015Q1$1.27$1.28$2.54 billion$25.00 billionViewListenView Earnings Details
2/11/2015Q414$1.51$1.56$2.72 billion$2.70 billionViewListenView Earnings Details
11/6/2014Q314$1.30$1.34$2.55 billion$2.62 billionViewListenView Earnings Details
8/4/2014Q214$1.33$1.35$2.56 billion$2.60 billionViewListenView Earnings Details
5/6/2014Q1$1.13$1.18$2.43 billion$2.40 billionViewListenView Earnings Details
2/11/2014Q413$1.39$1.43$2.53 billion$2.50 billionViewListenView Earnings Details
11/5/2013Q313$1.21$1.22$2.37 billion$2.30 billionViewListenView Earnings Details
8/6/2013Q2 2013$1.23$1.23$2.39 billion$2.40 billionViewListenView Earnings Details
5/7/2013Q1 2013$1.07$1.06$2.25 billion$2.30 billionViewListenView Earnings Details
2/13/2013Q4 2012$1.21$1.26$2.40 billion$2.40 billionViewListenView Earnings Details
11/7/2012Q312$1.07$1.08$2.24 billion$2.23 billionViewN/AView Earnings Details
8/2/2012$1.10$1.11ViewN/AView Earnings Details
5/8/2012$0.92$0.98ViewN/AView Earnings Details
2/15/2012$1.12$1.15ViewN/AView Earnings Details
11/1/2011$1.00$0.99ViewN/AView Earnings Details
8/2/2011$1.00$1.01ViewN/AView Earnings Details
5/3/2011$0.80$0.82ViewN/AView Earnings Details
2/22/2011$0.96$1.00ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Henry Schein (NASDAQ:HSIC)
Current Year EPS Consensus Estimate: $6.58 EPS
Next Year EPS Consensus Estimate: $8.01 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20166$1.37$1.55$1.45
Q2 20165$1.60$1.66$1.63
Q3 20165$1.65$1.71$1.68
Q4 20165$1.83$1.86$1.84
Q1 20175$1.60$1.68$1.63
Q2 20175$1.74$1.81$1.77
Q3 20175$1.79$1.85$1.83
Q4 20175$1.92$2.06$1.99
(Data provided by Zacks Investment Research)


Dividend History for Henry Schein (NASDAQ:HSIC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Henry Schein (NASDAQ:HSIC)
Insider Ownership Percentage: 1.27%
Institutional Ownership Percentage: 90.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/12/2016Kurt P KuehnDirectorBuy1,000$151.41$151,410.00View SEC Filing  
11/3/2016Mark E MlotekEVPSell2,417$155.19$375,094.23View SEC Filing  
8/29/2016Paul BronsDirectorSell3,381$164.03$554,585.43View SEC Filing  
6/2/2016Gerald A BenjaminEVPSell9,991$175.08$1,749,224.28View SEC Filing  
5/16/2016James A HardingSVPSell10,302$172.60$1,778,125.20View SEC Filing  
5/12/2016Peter M MccarthyInsiderSell1,158$171.75$198,886.50View SEC Filing  
3/15/2016Lonnie ShoffCEOSell3,028$168.29$509,582.12View SEC Filing  
3/14/2016David MckinleyInsiderSell3,339$167.92$560,684.88View SEC Filing  
3/14/2016Norman S MatthewsDirectorSell5,335$167.75$894,946.25View SEC Filing  
3/10/2016Donald J KabatDirectorSell1,218$168.38$205,086.84View SEC Filing  
3/7/2016Barry J AlperinDirectorSell1,635$167.36$273,633.60View SEC Filing  
3/7/2016Michael S EttingerSVPSell5,423$168.13$911,768.99View SEC Filing  
3/4/2016Philip A LaskawyDirectorSell1,317$166.88$219,780.96View SEC Filing  
3/2/2016Louis W SullivanDirectorSell11,735$168.59$1,978,403.65View SEC Filing  
3/2/2016Mark E MlotekEVPSell4,982$167.93$836,627.26View SEC Filing  
2/26/2016Barry J AlperinDirectorSell7,540$167.96$1,266,418.40View SEC Filing  
2/24/2016Robert MinowitzInsiderSell9,648$165.48$1,596,551.04View SEC Filing  
2/22/2016Michael RacioppiSVPSell21,567$166.74$3,596,081.58View SEC Filing  
2/17/2016Stanley KomaroffInsiderSell8,000$163.53$1,308,240.00View SEC Filing  
2/16/2016Norman S MatthewsDirectorSell4,230$160.05$677,011.50View SEC Filing  
2/12/2016Steven PaladinoCFOSell11,727$157.21$1,843,601.67View SEC Filing  
2/11/2016Donald J. KabatDirectorSell6,637$156.36$1,037,761.32View SEC Filing  
12/17/2015Michael RacioppiSVPSell9,901$155.92$1,543,763.92View SEC Filing  
12/10/2015Stanley M. BergmanCEOSell61,800$155.45$9,606,810.00View SEC Filing  
11/9/2015Paul RoseSVPSell3,638$151.92$552,684.96View SEC Filing  
11/5/2015Mark E. MlotekEVPSell2,952$155.00$457,560.00View SEC Filing  
11/5/2015Stanley KomaroffInsiderSell6,297$154.89$975,342.33View SEC Filing  
9/16/2015Philip A LaskawyDirectorSell4,000$136.20$544,800.00View SEC Filing  
5/6/2015Paul BronsDirectorSell3,801$136.70$519,596.70View SEC Filing  
3/19/2015Michael S EttingerSVPSell4,352$139.75$608,192.00View SEC Filing  
3/18/2015James P BreslawskiCEOSell12,811$139.45$1,786,493.95View SEC Filing  
3/17/2015Leonard A DavidSVPSell3,935$140.00$550,900.00View SEC Filing  
3/16/2015Paul RoseSVPSell3,264$140.13$457,384.32View SEC Filing  
3/13/2015Norman S MatthewsDirectorSell9,200$136.07$1,251,844.00View SEC Filing  
3/11/2015Philip A LaskawyDirectorSell2,669$136.60$364,585.40View SEC Filing  
3/10/2015Donald J KabatDirectorSell2,002$138.00$276,276.00View SEC Filing  
3/5/2015Barry J AlperinDirectorSell6,637$140.64$933,427.68View SEC Filing  
2/24/2015Stanley KomaroffInsiderSell8,000$141.69$1,133,520.00View SEC Filing  
2/12/2015Donald J KabatDirectorSell5,000$142.68$713,400.00View SEC Filing  
2/12/2015Gerald A BenjaminEVPSell22,116$142.71$3,156,174.36View SEC Filing  
2/12/2015Robert MinowitzInsiderSell11,254$142.63$1,605,158.02View SEC Filing  
12/18/2014Leonard A DavidSVPSell3,557$135.34$481,404.38View SEC Filing  
12/9/2014Stanley M BergmanCEOSell69,600$135.56$9,434,976.00View SEC Filing  
12/8/2014Stanley M BergmanCEOSell23,485$136.34$3,201,944.90View SEC Filing  
11/24/2014Stanley KomaroffInsiderSell13,757$133.06$1,830,506.42View SEC Filing  
11/7/2014Lorelei McglynnSVPSell15,746$129.03$2,031,706.38View SEC Filing  
11/7/2014Mark E MlotekEVPSell6,262$128.75$806,232.50View SEC Filing  
9/2/2014Philip A LaskawyDirectorSell15,438$119.40$1,843,297.20View SEC Filing  
8/29/2014Louis W SullivanDirectorSell17,262$119.99$2,071,267.38View SEC Filing  
6/9/2014Barry J AlperinDirectorSell7,500$120.39$902,925.00View SEC Filing  
6/2/2014Gerald A BenjaminEVPSell12,354$119.50$1,476,303.00View SEC Filing  
5/28/2014Norman S MatthewsDirectorSell6,637$118.68$787,679.16View SEC Filing  
5/19/2014Donald KabatDirectorSell5,000$116.30$581,500.00View SEC Filing  
5/15/2014Paul BronsDirectorSell5,363$113.77$610,148.51View SEC Filing  
3/19/2014Barry AlperinDirectorSell7,500$119.18$893,850.00View SEC Filing  
3/17/2014Lonnie ShoffCEOSell3,722$119.06$443,141.32View SEC Filing  
3/12/2014Michael EttingerSVPSell3,537$119.20$421,610.40View SEC Filing  
3/11/2014David MckinleyInsiderSell2,387$119.65$285,604.55View SEC Filing  
3/11/2014James BreslawskiCEOSell72,642$119.35$8,669,822.70View SEC Filing  
3/11/2014Paul RoseSVPSell3,783$119.72$452,900.76View SEC Filing  
3/10/2014Robert MinowitzInsiderSell11,553$119.98$1,386,128.94View SEC Filing  
3/4/2014Donald KabatDirectorSell5,000$119.15$595,750.00View SEC Filing  
2/28/2014Michael RacioppiSVPSell18,614$118.91$2,213,390.74View SEC Filing  
2/26/2014Stanley KomaroffInsiderSell18,000$119.36$2,148,480.00View SEC Filing  
2/25/2014Mark MlotekEVPSell20,333$119.16$2,422,880.28View SEC Filing  
2/20/2014Steven PaladinoCFOSell28,757$117.79$3,387,287.03View SEC Filing  
2/12/2014Philip LaskawyDirectorSell5,851$114.91$672,338.41View SEC Filing  
12/19/2013Mark MlotekEVPSell22,004$111.97$2,463,787.88View SEC Filing  
12/19/2013Michael RacioppiSVPSell29,257$111.97$3,275,906.29View SEC Filing  
12/17/2013Gerald BenjaminEVPSell41,664$111.66$4,652,202.24View SEC Filing  
12/17/2013James BreslawskiCEOSell57,754$111.91$6,463,250.14View SEC Filing  
12/16/2013Steven PaladinoCFOSell47,652$112.31$5,351,796.12View SEC Filing  
12/13/2013Stanley BergmanCEOSell78,000$111.90$8,728,200.00View SEC Filing  
12/6/2013Leonard DavidSVPSell13,968$113.14$1,580,339.52View SEC Filing  
11/26/2013Stanley KomaroffInsiderSell22,329$114.79$2,563,145.91View SEC Filing  
8/23/2013Philip LaskawyDirectorSell21,637$103.17$2,232,289.29View SEC Filing  
8/22/2013Norman MatthewsDirectorSell9,851$103.95$1,024,011.45View SEC Filing  
8/20/2013Louis SullivanDirectorSell15,000$103.91$1,558,650.00View SEC Filing  
8/12/2013Donald KabatDirectorSell2,500$106.25$265,625.00View SEC Filing  
6/18/2013Barry J AlperinDirectorSell7,500$97.74$733,050.00View SEC Filing  
5/8/2013James A HardingCTOSell12,000$92.64$1,111,680.00View SEC Filing  
3/8/2013Donald J KabatDirectorSell4,038$90.00$363,420.00View SEC Filing  
12/4/2012Donald J KabatDirectorSell15,000$80.04$1,200,600.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Henry Schein (NASDAQ:HSIC)
News IconIs a Pullback Coming For Henry Schein, Inc. (NASDAQ:HSIC)? - Aiken Advocate (NASDAQ:HSIC)
aikenadvocate.com - February 22 at 5:55 PM
News IconThe Bears And Bulls Square Off On Henry Schein, Inc. (HSIC) - NY Stock News (NASDAQ:HSIC)
nystocknews.com - February 22 at 5:55 PM
rttnews.com logoHenry Schein Inc. (HSIC) Jumped On Better Than Expected Q4 Earnings - RTT News (NASDAQ:HSIC)
www.rttnews.com - February 22 at 5:55 PM
News IconHenry Schein Reports Record Fourth Quarter And Full Year 2016 Financial Results (NASDAQ:HSIC)
www.yahoo.com - February 22 at 12:48 PM
4-traders.com logoHENRY SCHEIN, INC. (NASDAQ:HSIC) Files An 8-K Results of Operations and Financial Condition (NASDAQ:HSIC)
www.4-traders.com - February 22 at 12:48 PM
nasdaq.com logoHenry Schein Reaches Analyst Target Price (NASDAQ:HSIC)
www.nasdaq.com - February 22 at 12:48 PM
News IconMedical Equipment Wholesale: Henry Schein, Inc. (NASDAQ:HSIC) Position of the day (NASDAQ:HSIC)
twincountynews.com - February 22 at 12:48 PM
seekingalpha.com logoHenry Schein (HSIC) Q4 2016 Results - Earnings Call Transcript (NASDAQ:HSIC)
seekingalpha.com - February 22 at 12:48 PM
News IconHenry Schein, Inc. (HSIC) Updates FY17 Earnings Guidance (NASDAQ:HSIC)
prensariotiretail.com - February 22 at 12:48 PM
News IconShares in Henry Schein, Inc. (HSIC) Acquired by ART Advisors LLC (NASDAQ:HSIC)
techknowbits.com - February 22 at 12:48 PM
us.rd.yahoo.com logo7:10 am Henry Schein beats by $0.04, beats on revs; reaffirms FY17 EPS guidance (NASDAQ:HSIC)
us.rd.yahoo.com - February 22 at 12:48 PM
biz.yahoo.com logoHENRY SCHEIN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:HSIC)
us.rd.yahoo.com - February 22 at 12:48 PM
us.rd.yahoo.com logoHenry Schein (HSIC) Tops Q4 Earnings and Revenues Estimates (NASDAQ:HSIC)
us.rd.yahoo.com - February 22 at 12:48 PM
sg.finance.yahoo.com logoHenry Schein tops Street 4Q forecasts (NASDAQ:HSIC)
sg.finance.yahoo.com - February 22 at 12:48 PM
finance.yahoo.com logoEdited Transcript of HSIC earnings conference call or presentation 21-Feb-17 3:00pm GMT (NASDAQ:HSIC)
finance.yahoo.com - February 22 at 12:48 PM
finance.yahoo.com logoHenry Schein Medical Announces Exclusive Distribution Agreement For Rijuven's CardioSleeve (NASDAQ:HSIC)
finance.yahoo.com - February 22 at 12:48 PM
capitalcube.com logoHenry Schein, Inc. :HSIC-US: Earnings Analysis: Q4, 2016 By the Numbers : February 22, 2017 (NASDAQ:HSIC)
www.capitalcube.com - February 22 at 12:48 PM
feeds.benzinga.com logoEarnings Scheduled For February 21, 2017 (NASDAQ:HSIC)
feeds.benzinga.com - February 21 at 6:00 AM
finance.yahoo.com logoHenry Schein To Acquire Southern Anesthesia + Surgical (NASDAQ:HSIC)
finance.yahoo.com - February 20 at 5:14 PM
finance.yahoo.com logoHenry Schein To Acquire Southern Anesthesia + Surgical (NASDAQ:HSIC)
finance.yahoo.com - February 20 at 5:14 PM
News IconPeeling Back The Layers on Henry Schein, Inc. (NASDAQ:HSIC): Analysts & Street Weigh In - Winfield Review (NASDAQ:HSIC)
winfieldreview.com - February 15 at 5:06 AM
News IconSADIF Analytics releases new summary due diligence report for Henry Schein Inc ($HSIC). (NASDAQ:HSIC)
reports.pr-inside.com - February 10 at 6:29 PM
News IconShares of Henry Schein, Inc. (HSIC) Sees Large Outflow of Money - Highland Mirror (NASDAQ:HSIC)
www.highlandmirror.com - February 9 at 11:39 PM
finance.yahoo.com logoHenry Schein Names Bridget A. Ross To Lead Global Medical Group (NASDAQ:HSIC)
finance.yahoo.com - February 9 at 6:38 PM
prnewswire.com logoHenry Schein To Webcast Fourth Quarter and Full Year 2016 Conference Call on ... (NASDAQ:HSIC)
www.prnewswire.com - February 7 at 7:02 PM
finance.yahoo.com logoHenry Schein To Webcast Fourth Quarter and Full Year 2016 Conference Call on Tuesday, February 21, 2017 at 10:00 a.m. ET (NASDAQ:HSIC)
finance.yahoo.com - February 7 at 7:02 PM
realistinvestor.com logoHenry Schein, Inc. (NASDAQ:HSIC) Mean Rating At $2 - RealistInvestor.com (NASDAQ:HSIC)
www.realistinvestor.com - February 5 at 5:32 PM
nasdaq.com logoHenry Schein, Inc. (Nasdaq: HSIC) to Ring The Nasdaq Stock ... - Nasdaq (NASDAQ:HSIC)
www.nasdaq.com - February 3 at 11:20 PM
finance.yahoo.com logoRegulations should be equal throughout the world: Henry S... (NASDAQ:HSIC)
finance.yahoo.com - February 3 at 6:19 PM
finance.yahoo.com logoHenry Schein Animal Health Launches Products, Services, And Solutions Designed To Empower Practices At 2017 North American Veterinary Community Conference (NASDAQ:HSIC)
finance.yahoo.com - February 3 at 6:19 PM
finance.yahoo.com logoHenry Schein To Open Nasdaq In Celebration Of 15th Annual Give Kids A Smile® Program (NASDAQ:HSIC)
finance.yahoo.com - February 2 at 6:25 PM
finance.yahoo.com logoHenry Schein, Inc. (Nasdaq: HSIC) to Ring The Nasdaq Stock Market Opening Bell (NASDAQ:HSIC)
finance.yahoo.com - February 2 at 6:25 PM
nasdaq.com logoInteresting HSIC Put And Call Options For March 17th (NASDAQ:HSIC)
www.nasdaq.com - February 1 at 6:30 PM
4-traders.com logoHenry Schein : Joins Takara Belmont To Support Oral Health Of At-Risk Youth In Israel By Donating State-Of-The-Art Equipment (NASDAQ:HSIC)
www.4-traders.com - January 31 at 6:28 PM
finance.yahoo.com logoHenry Schein Recognizes Responsible Pet Owners Month By Reminding Pet Parents To Take Their Pets To The Vet (NASDAQ:HSIC)
finance.yahoo.com - January 31 at 6:28 PM
finance.yahoo.com logoHenry Schein Joins Takara Belmont To Support Oral Health Of At-Risk Youth In Israel By Donating State-Of-The-Art Equipment (NASDAQ:HSIC)
finance.yahoo.com - January 30 at 11:11 AM
News IconLooking at the Numbers for Henry Schein, Inc. (NASDAQ:HSIC) - Gilbert Daily (NASDAQ:HSIC)
gilbertdaily.com - January 29 at 5:47 PM
realistinvestor.com logoMean Rating Of Henry Schein, Inc. (NASDAQ:HSIC) At $2 - RealistInvestor.com (NASDAQ:HSIC)
www.realistinvestor.com - January 29 at 5:47 PM
nasdaq.com logoHenry Schein (HSIC) Q4 Earnings: Disappointment in Store? - Nasdaq (NASDAQ:HSIC)
www.nasdaq.com - January 29 at 5:47 PM
finance.yahoo.com logoHenry Schein (HSIC) Q4 Earnings: Disappointment in Store? (NASDAQ:HSIC)
finance.yahoo.com - January 27 at 7:41 PM
nasdaq.com logoAgree To Buy Henry Schein At $145, Earn 4.7% Annualized Using Options (NASDAQ:HSIC)
www.nasdaq.com - January 27 at 6:02 AM
News IconEarnings in Full Force, Analysts Take Aim at Henry Schein, Inc. (NASDAQ:HSIC) - Wall Street Beacon (NASDAQ:HSIC)
wsbeacon.com - January 26 at 7:24 PM
finance.yahoo.com logoHenry Schein Announces Finalists For Second Annual Henry Schein Cares Medal (NASDAQ:HSIC)
finance.yahoo.com - January 26 at 7:24 PM
News IconInstitutions Holding Steady in Their Positions of Henry Schein, Inc. (NASDAQ:HSIC) - Wall Street Beacon (NASDAQ:HSIC)
wsbeacon.com - January 26 at 1:18 AM
News IconStock Perspective: Henry Schein, Inc. (NASDAQ:HSIC) Company Earnings Watch - Aiken Advocate (NASDAQ:HSIC)
aikenadvocate.com - January 25 at 3:15 PM
streetinsider.com logoHenry Schein (HSIC) Acquires 51% Stake in Tecnew, Entering Brazilian Market - StreetInsider.com (NASDAQ:HSIC)
www.streetinsider.com - January 25 at 3:15 PM
finance.yahoo.com logoHenry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Tornadoes In The South (NASDAQ:HSIC)
finance.yahoo.com - January 25 at 3:15 PM
marketnewsvideo.com logoNotable Tuesday Option Activity: IBM, HSIC, WDC (NASDAQ:HSIC)
www.marketnewsvideo.com - January 24 at 6:30 PM
News IconHenry Schein, Inc. (NASDAQ:HSIC) from Medical Equipment Wholesale – Todays Top Gains (NASDAQ:HSIC)
twincountynews.com - January 24 at 6:30 PM
News IconUpdate on Henry Schein, Inc. (NASDAQ:HSIC) for the day (NASDAQ:HSIC)
twincountynews.com - January 23 at 6:01 PM


What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Where is Henry Schein's stock going? Where will Henry Schein's stock price be in 2017?

10 brokerages have issued 12-month target prices for Henry Schein's stock. Their forecasts range from $163.00 to $208.00. On average, they expect Henry Schein's share price to reach $181.88 in the next year.

When will Henry Schein announce their earnings?

Henry Schein is scheduled to release their next quarterly earnings announcement on Monday, May, 1st 2017.

What are analysts saying about Henry Schein stock?

Here are some recent quotes from research analysts about Henry Schein stock:

  • Evercore ISI analysts commented, "HSIC continues to deliver consistent HSD to LDD EPS growth despite an operating environment that has been somewhat mixed, albeit North American Dental continues to show signs of recovery. With the acquisition engine still churning and an elevated level of buybacks, management has been able to deliver the type of TSR expected and thus the valuation remains notably elevated on an absolute basis (less so on a relative basis). While we also value consistency and predictability, we acknowledge we missed the November entry point (fears of US slowdown) and thus at current levels see risk / reward as more fully balanced (particularly with extra week headwind in 2017 + unfavorable Fx environment). Given this dynamic we reiterate our Hold rating and argue shares are now accurately pricing in the current operating environment. Thus we await another period of uncertainty prior to revisiting our long-term constructive view on shares." (2/21/2017)
  • According to Zacks Investment Research, "In the last three months, Henry Schein’s share price trend witnessed a neck and neck movement with the broader Medical product market trend. However the trend surpassed the latter on posting third quarter 2016 earnings. The results were mixed with earnings beating the Zacks Consensus Estimate and revenues meeting the mark. Also the company’s strong share gains in both North American and overseas markets raise optimism. We also keenly await Henry Schein’s impending acquisition of Marrodent which should help the former to capture the bountiful dental market opportunities in Poland. Despite each segment’s strong sales growth, the company’s unchanged EPS guidance for 2016 was disappointing. The year-over-year decline in Henry Schein’s gross and operating margin due to higher cost of sales and expenses also concerns us. Meanwhile, foreign currency fluctuations continued to hamper the company’s business." (1/9/2017)

Who owns Henry Schein stock?

Henry Schein's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (8.98%), State Street Corp (4.51%), Janus Capital Management LLC (2.72%), Atlanta Capital Management Co. L L C (1.82%), Franklin Resources Inc. (0.69%) and Renaissance Technologies LLC (0.59%). Company insiders that own Henry Schein stock include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, James P Breslawski, Kurt P Kuehn, Leonard A David, Lonnie Shoff, Louis W Sullivan, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Norman S Matthews, Paul Brons, Paul Rose, Peter M Mccarthy, Philip A Laskawy, Robert Minowitz, Stanley Komaroff, Stanley M Bergman and Steven Paladino.

Who sold Henry Schein stock? Who is selling Henry Schein stock?

Henry Schein's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Aviva PLC, Fiera Capital Corp, Martingale Asset Management L P, Comerica Bank, AQR Capital Management LLC, Ativo Capital Management LLC and Credit Agricole S A. Company insiders that have sold Henry Schein stock in the last year include Barry J Alperin, David Mckinley, Donald J Kabat, Gerald A Benjamin, James A Harding, Lonnie Shoff, Louis W Sullivan, Mark E Mlotek, Michael Racioppi, Michael S Ettinger, Norman S Matthews, Paul Brons, Peter M Mccarthy, Philip A Laskawy and Robert Minowitz.

Who bought Henry Schein stock? Who is buying Henry Schein stock?

Henry Schein's stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Congress Asset Management Co. MA, Champlain Investment Partners LLC, Atlanta Capital Management Co. L L C, Asset Management One Co. Ltd., AMF Pensionsforsakring AB, Russell Investments Group Ltd. and Bluestein R H & Co..

How do I buy Henry Schein stock?

Shares of Henry Schein can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Henry Schein stock cost?

One share of Henry Schein stock can currently be purchased for approximately $172.64.

Henry Schein (NASDAQ:HSIC) Chart for Wednesday, February, 22, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Earnings History Chart

Earnings by Quarter for Henry Schein (NASDAQ:HSIC)

Dividend History Chart

Dividend Payments by Quarter for Henry Schein (NASDAQ:HSIC)

Last Updated on 2/22/2017 by MarketBeat.com Staff